TGFB1 and diabetic kidney disease: Similarly, in models of obstructive and DKD, it has been demonstrated that Ang-(1-7) reduced TGFβ1 expression and signaling through TGFβ1/Smad complex and that these effects were reversed by Mas receptor blockade (Liu et al., 2012).